NEU 1.07% $14.20 neuren pharmaceuticals limited

preventing tbi?, page-15

  1. 10,009 Posts.
    All of our programs would be eligble... The company has twice reported reduced death rates in TBI trials. With 100 patients dosed , that should be sufficient. Maybe the application is in the FDA as wespeak.

    And FRAG X and RETTS. All fit the criteria...

    And they have plenty of safety data....
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.